Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Werner Edward CooperChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $23K 80 sh | Mar 5, 2026 |
| 5 | Kalia KumudChief Information Officer | Option exercise | M | — 1,000 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Werner Edward CooperChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $11K 40 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Werner Edward CooperChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $23K 80 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Kalia KumudChief Information Officer | Option exercise | M | — 10.0K sh | Mar 5, 2026 traded Mar 4, 2026 |
| 5 | Silva Effie DSVP, General Counsel & Secy | Option exercise | M | — 151 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 5 | Kalia KumudChief Information Officer | Option exercise | M | — 2,119 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 2 | Dechairo BryanChief Operating Officer | Grant or award | A | — 10.4K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 2 | Feeley KevinCHIEF FINANCIAL OFFICER | Grant or award | A | — 10.9K sh | Mar 5, 2026 traded Mar 3, 2026 |
| 1 | Hopman MarkChief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $4,084 353 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 0 | McNamara PeterChief Scientific Officer | Grant or award · 10b5-1 plan | A | — 21.0K sh | Mar 5, 2026 traded Mar 4, 2026 |
| 0 | Bick Karen M.SVP - Chief People Officer | Tax withholding · 10b5-1 plan | F | $39K 841 sh | Mar 5, 2026 traded Mar 3, 2026 |
| 0 | Bick Karen M.SVP - Chief People Officer | Tax withholding · 10b5-1 plan | F | $34K 733 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,438 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | $20K 2,438 sh | Mar 5, 2026 traded Mar 4, 2026 |
| 65 | Musser ForySenior VP, Development | Open-market sale | SELL | $10.90M 1.00M sh | Mar 4, 2026 traded Mar 4, 2026 |
| 47 | Sorrentino CharlesDirector, Co-CIO | Open-market purchase | BUY | $300K 14.9K sh | Mar 4, 2026 traded Mar 2, 2026 |
| 44 | McMahon Stephen AEVP, Chief Customer Officer | Open-market purchase | BUY | $107K 3,000 sh | Mar 4, 2026 traded Mar 3, 2026 |
| 43 | Carlson MeganCAO and SVP, Finance | Open-market sale | SELL | $156K 42.0K sh | Mar 4, 2026 traded Mar 3, 2026 |
| 42 | Devivo JosephDirector, President & CEO | Open-market sale | SELL | $599K 161.3K sh | Mar 4, 2026 traded Mar 3, 2026 |
| 36 | Holt MichaelChief Financial Officer | Open-market purchase | BUY | $187K 1,000 sh | Mar 4, 2026 traded Mar 4, 2026 |
| 35 | Caezza NicholasDeputy General Counsel | Open-market sale | SELL | $53K 14.2K sh | Mar 4, 2026 traded Mar 3, 2026 |
| 35 | Sparks Paul EugeneDirector | Open-market purchase | BUY | $666K 29.0K sh | Mar 4, 2026 traded Mar 2, 2026 |
| 35 | Cashman SteveChief Business Officer | Open-market sale | SELL | $158K 42.5K sh | Mar 4, 2026 traded Mar 3, 2026 |
| 31 | Sparks Paul EugeneDirector | Open-market purchase | BUY | $336K 15.2K sh | Mar 4, 2026 traded Mar 3, 2026 |
| 31 | Canup Edward GCHIEF BANKING OFFICER | Open-market purchase | BUY | $10K 500 sh | Mar 4, 2026 traded Feb 27, 2026 |
| 31 | Canup Edward GCHIEF BANKING OFFICER | Open-market purchase | BUY | $10K 500 sh | Mar 4, 2026 traded Feb 27, 2026 |
| 31 | Hammad Hanei WailEVP & Chief Operating Officer | Disposition to issuer | D | $69K 6,384 sh | Mar 4, 2026 traded Mar 25, 2025 |
| 31 | Vieira CoryChief Accounting Officer | Open-market sale | SELL | $27K 2,490 sh | Mar 4, 2026 traded Mar 2, 2026 |
| 30 | Mukkamala Himagiri KChief Operating Officer | Open-market sale | SELL | $89K 1,793 sh | Mar 4, 2026 traded Mar 4, 2026 |
| 29 | O'Dea Regan PatrickVP, General Counsel | Open-market purchase | BUY | $45K 578 sh | Mar 4, 2026 traded Mar 2, 2026 |
| 29 | Read BrianChief Financial Officer | Open-market sale | SELL | $12K 1,268 sh | Mar 4, 2026 traded Mar 3, 2026 |
| 29 | Strausbaugh Sue AnnDirector | Open-market purchase | BUY | $993 48 sh | Mar 4, 2026 traded Mar 4, 2026 |
| 28 | Thompson-Byas BenitaDirector | Open-market sale | SELL | $71K 2,000 sh | Mar 4, 2026 traded Mar 3, 2026 |
| 27 | Hammad Hanei WailEVP & Chief Operating Officer | Grant or award | A | — 29.8K sh | Mar 4, 2026 traded Feb 25, 2026 |
| 26 | Brown Erin ElizabethChief Operating Officer | Tax withholding | F | $1.14M 55.4K sh | Mar 4, 2026 traded Mar 2, 2026 |
| 25 | Hunstad MichaelPresident/Asset Management | Tax withholding | F | $554K 3,867 sh | Mar 4, 2026 traded Mar 1, 2026 |
| 25 | Thornton David JohnMD, Americas | Open-market sale · 10b5-1 plan | SELL | $973K 8,060 sh | Mar 4, 2026 traded Mar 3, 2026 |
| 24 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.54M 24.2K sh | Mar 4, 2026 traded Mar 2, 2026 |
| 24 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $2.57M 40.0K sh | Mar 4, 2026 traded Mar 2, 2026 |